CN109735655A - It is a kind of to detect DNA simultaneously and the multiple fluorescence PCR of RNA prestores freeze-dried reagent - Google Patents
It is a kind of to detect DNA simultaneously and the multiple fluorescence PCR of RNA prestores freeze-dried reagent Download PDFInfo
- Publication number
- CN109735655A CN109735655A CN201910055286.6A CN201910055286A CN109735655A CN 109735655 A CN109735655 A CN 109735655A CN 201910055286 A CN201910055286 A CN 201910055286A CN 109735655 A CN109735655 A CN 109735655A
- Authority
- CN
- China
- Prior art keywords
- freeze
- rna
- pcr
- reagent
- final concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention provides a kind of multiple fluorescence PCRs that can detect DNA and RNA simultaneously to prestore freeze-dried reagent, includes reverse transcriptase, archaeal dna polymerase;PCR buffer;Mg2+;dNTP;Freeze drying protectant.The present invention can carry out multiple fluorescence PCR augmentation detection for the two distinct types of nucleic acid of DNA and RNA simultaneously in same reaction tube, can solve for different types of nucleic acid, need the case where repeatedly expanding, save time and consumables cost.
Description
Technical field
The invention belongs to bioengineering fields, are related to a kind of detection reagent, specifically it is a kind of can detect simultaneously DNA and
The multiple fluorescence PCR of RNA prestores freeze-dried reagent.
Background technique
Polymerase chain reaction (Polymerase Chain Reaction), abbreviation PCR is a kind of Amplification Technologies,
It, will be to be amplified dependent on the enzymatic reaction of polymerase under the conditions of being existing for template nucleic acid, primer and the deoxynucleotide
DNA fragmentation obtains a large amount of specific gene segment through iterative cycles in a short time.Have many advantages, such as sensitive high, high specificity,
It is now widely used for diagnostic nucleic acid field.
Fluorescent PCR (Real-time PCR), also known as real-time fluorescence PCR, refer to and fluorescent base are added in PCR reaction system
The entire PCR process of real-time monitoring is accumulated using fluorescence signal by group, carries out macroanalysis to unknown template finally by standard curve
Or relative quantification is carried out to template by Ct value.Fluorescent PCR can be divided into sonde method and dye method according to the difference of the principles of chemistry.Its
In, for Taqman fluorescent quantitation technology based on Taqman fluorescence probe, this probe is an oligonucleotides, at 5 ' ends of sequence
It is marked with a fluorescent emission group, a quenching group is marked at 3 ' ends, when probe is complete, emits the fluorescence signal of group
Group absorptions are quenched, when PCR amplification, since the circumscribed enzyme effect of Taq enzyme makes probe degrade, to make fluorophor
Fluorescence is issued, fluorescent PCR instrument detects sample by detecting the accumulation of fluorescence signal.
Multiple fluorescence PCR (multiplex PCR), also known as multi-primers fluorescent PCR or composite PCR, it is in same PCR
Primer, probe in reaction system plus two pairs or more, so that the different nucleic acid fragments to two or more carry out PCR expansion
Increase.Certain pathogenic microorganisms, certain hereditary diseases are detected or identified while multiplex PCR is mainly used for a variety of specialized hospital microorganisms.Mesh
Before, the multiple fluorescence PCR reagent based on fluorescence probe, which is substantially, detects same type of nucleic acid, is such as all directed to
The nucleic acid of DNA class carries out multiple fluorescence PCR, or all carries out multiple fluorescence PCR for the nucleic acid of RNA class.
The fluorescence PCR detection reagent for being conventionally used to DNA and RNA is mostly the substance detection reagent of liquid, a reaction system
A target can only be detected, detection project is single, consumptive material and reagent cost are high, and detection flux is low.Simultaneously as being liquid condition
Reagent needs cryo-conservation to transport during transportation, increases the cost and complexity of transport.
Current PCR amplification reagent is in liquid condition substantially, is saved at normal temperature and unstable, especially RNA reaction examination
Agent.And liquid reagent has a significant impact to the activity of reagent every time using multigelation is required, to the long-distance fortune of PCR reagent
It is defeated to will receive very big influence, it is easy that reagent performance is caused to decline because temperature is improper.Of the invention can detect DNA and RNA simultaneously
Multiplex PCR pre-freeze reagent can effectively overcome disadvantages mentioned above.
Summary of the invention
For above-mentioned technical problem in the prior art, the multiple of DNA and RNA can be detected simultaneously the present invention provides a kind of
Fluorescent PCR prestores freeze-dried reagent, and this multiple fluorescence PCR that can detect DNA and RNA simultaneously prestores freeze-dried reagent and wants
Solve the fluorescence PCR detection reagent in the prior art for DNA and RNA can only detect a target/detection project it is single, consumption
Material and the technical problem that reagent cost height/detection flux is low and transport is inconvenient.
The present invention provides a kind of multiple fluorescence PCRs that can detect DNA and RNA simultaneously to prestore freeze-dried reagent, comprising following
Component:
Reverse transcriptase, the final concentration of 0.02U/ul-0.2U/ul of the reverse transcriptase;
Archaeal dna polymerase, the final concentration of 0.05U/ul-0.1U/ul of the archaeal dna polymerase;
PCR buffer, the PCR buffer is by the KCl of final concentration of 10mM-50mM, final concentration of 5mM-30mM
Tris-HCl, whole mass percent concentration are 0.005%-0.05%Tween20 composition;
Mg2+, the Mg2+Final concentration of 1.5mM-5mM;
The final concentration of 0.1mM-0.5mM of dNTP, the dNTP;
Freeze drying protectant, the freeze drying protectant are dense by the trehalose that whole mass percent concentration is 0.5%-5%, end
Spend the D-sorbite for being 5mM-100mM, BSA (bovine serum albumin(BSA)) group that whole mass percent concentration is 0.2%-1.5%
At.
The present invention can carry out multi-fluorescence for the two distinct types of nucleic acid of DNA and RNA simultaneously in same reaction tube
PCR amplification detection can solve for different types of nucleic acid, need the case where repeatedly expanding, save time and consumptive material
Cost.
The present invention is compared with prior art, and technological progress is significant.It is of the invention can freeze-dried reagent can be to two kinds not
The pathogen nucleic acid of same type carries out augmentation detection, i.e., detected simultaneously using a reaction system DNA (hepatitis type B virus) and
Reagent and detection consumptive material is greatly saved in RNA (Hepatitis C Virus) different types of target.Meanwhile after reagent is lyophilized,
Has many advantages, such as convenient transportation, stability is good.
Specific embodiment
Embodiment 1
1) the present invention provides a kind of multiple fluorescence PCRs that can detect DNA and RNA simultaneously to prestore freeze-dried reagent, ingredient
Reverse transcriptase containing 0.02U/ul-0.2U/ul, the archaeal dna polymerase of 0.05U/ul-0.1U/ul, the Mg of 1.5mM-5mM2+,
The dNTP of 0.1mM-0.5mM, 10mM-50mM KCl, 5mM-30mM Tris-HCl, 0.005%-0.05% Tween20,
0.5%-5% trehalose, 5mM-100mM D-sorbite, 0.2%-1.5%BSA.DNA and RNA nucleic acid can be examined simultaneously
It surveys.
2) concrete scheme is as follows:
1, experimental group (freeze-dried reagent) formula is as follows:
Concentration | |
KCl | 25mM |
Tris-HCl | 20mM |
Tween20 | 0.01% |
Mg2+ | 3mM |
dNTP | 0.2mM |
Archaeal dna polymerase | 0.05U/ul |
Reverse transcriptase | 0.05U/ul |
Trehalose | 0.5% |
D-sorbite | 10mM |
BSA | 0.5% |
HBV-F | 0.2uM |
HBV-R | 0.2uM |
HBV-P | 0.05uM |
HCV-F | 0.2uM |
HCV-R | 0.2uM |
HCV-P | 0.05uM |
After being made into liquid reagent by upper table formula, liquid reagent is put into pre-freeze device, liquid reagent is pre- at -50 DEG C
Freeze, is gradually warmed up and carries out vacuum freeze drying.
2, control group (liquid reagent) formula is as follows:
Oscillation mixes, and is dispensed into 8 company, 96 orifice plate.
HBV-F sequence are as follows: 5 '-tcgcatcaggactcctaggacc-3 ' (shown in SEQ ID NO.1);
HBV-R sequence are as follows: 5 '-cgagtctagactctgtggtattgtgagg-3 ' (shown in SEQ ID NO.2);
HBV-P probe sequence are as follows: 5 '-CY5-ctgctcgtgttacaggcggggtttttcttg-BHQ3-3 ' (SEQ ID
Shown in NO.3);
HCV-F sequence are as follows: 5 '-ctagccatggcgttagtatgagtgt-3 ' (shown in SEQ ID NO.4);
HCV-R sequence are as follows: 5 '-tggcaattccggtgtactcac-3 ' (shown in SEQ ID NO.5);
HCV-P probe sequence are as follows: 5 '-FAM-cgggagagccatagtggtctgcggaa-BHQ1-3 ' (SEQ ID NO.6
It is shown);
3, DNA and RNA is extracted from clinical sample blood plasma, is added separately to the good experimental group of above-mentioned packing and control group examination
In agent.
4, setting program is as follows:
50 DEG C, 25min;95 DEG C, 10min;
5 × (95 DEG C, 15S;55 DEG C, 20S;72 DEG C, 20S;)
45 × (95 DEG C, 10S;60 DEG C, 45S;Acquire fluorescence;)
5, experimental group and control group testing result are as follows:
5.1 Table A DNA testing results
Group number | Sensitivity |
Experimental group | 10IU |
Control group | 10IU |
Table B RNA testing result
Group number | Sensitivity |
Experimental group | 50IU |
Control group | 50IU |
By Table A, table B it is found that experimental group (freeze-dried reagent) and contrast agents (liquid reagent) detection sensitivity are almost the same,
Freeze-dried reagent is able to maintain the high sensitivity of liquid reagent.
The advantage of the invention is that detection reagent can detect the two distinct types of nucleic acid of DNA and RNA simultaneously, it is able to achieve pair
The detection of multiple nucleic acids is greatly saved kit detection consumptive material, expands application range.The freeze-dried reagent that prestores of the invention exists
After frozen dried, reagent is allowed to have many advantages, such as convenient transportation, stability is good.
Claims (1)
- DNA can be detected simultaneously and the multiple fluorescence PCR of RNA prestores freeze-dried reagent 1. a kind of, it is characterised in that include following component:Reverse transcriptase, the final concentration of 0.02U/ul-0.2U/ul of the reverse transcriptase;Archaeal dna polymerase, the final concentration of 0.05U/ul-0.1U/ul of the archaeal dna polymerase;PCR buffer, the PCR buffer is by the KCl of final concentration of 10mM-50mM, final concentration of 5mM-30mM Tris-HCl, whole mass percent concentration are 0.005%-0.05% Tween20 composition;Mg2+, the Mg2+Final concentration of 1.5mM-5mM;The final concentration of 0.1mM-0.5mM of dNTP, the dNTP;Freeze drying protectant, the trehalose, final concentration of that the freeze drying protectant is 0.5%-5% by whole mass percent concentration The BSA that the D-sorbite of 5mM-100mM, whole mass percent concentration are 0.2%-1.5% is formed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910055286.6A CN109735655A (en) | 2019-01-21 | 2019-01-21 | It is a kind of to detect DNA simultaneously and the multiple fluorescence PCR of RNA prestores freeze-dried reagent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910055286.6A CN109735655A (en) | 2019-01-21 | 2019-01-21 | It is a kind of to detect DNA simultaneously and the multiple fluorescence PCR of RNA prestores freeze-dried reagent |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109735655A true CN109735655A (en) | 2019-05-10 |
Family
ID=66365487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910055286.6A Pending CN109735655A (en) | 2019-01-21 | 2019-01-21 | It is a kind of to detect DNA simultaneously and the multiple fluorescence PCR of RNA prestores freeze-dried reagent |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109735655A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114752662A (en) * | 2022-02-25 | 2022-07-15 | 福州迈新生物技术开发有限公司 | Fluorescent PCR (polymerase chain reaction) freeze-drying protective agent and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6153412A (en) * | 1998-12-07 | 2000-11-28 | Bioneer Corporation | Lyophilized reagent for polymerase chain reaction |
CN105349529A (en) * | 2015-12-09 | 2016-02-24 | 江苏正大天创生物工程有限公司 | Freeze-drying protective agent applied to nucleic acid amplification system |
CN105463125A (en) * | 2016-02-02 | 2016-04-06 | 江苏正大天创生物工程有限公司 | Nucleic acid amplification system and freeze-drying protective agent thereof |
CN105624311A (en) * | 2016-03-08 | 2016-06-01 | 湖南圣湘生物科技有限公司 | Real-time fluorescent PCR detection method and kit of multiple target nucleic acid in single tube |
CN106591432A (en) * | 2016-10-19 | 2017-04-26 | 珠海丽珠试剂股份有限公司 | Freeze-drying protective agent and freeze-drying method for RNA amplification reaction agent |
CN107287348A (en) * | 2017-06-19 | 2017-10-24 | 广州和实生物技术有限公司 | A kind of blood sieves three polychrome single tube detection kits |
-
2019
- 2019-01-21 CN CN201910055286.6A patent/CN109735655A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6153412A (en) * | 1998-12-07 | 2000-11-28 | Bioneer Corporation | Lyophilized reagent for polymerase chain reaction |
CN105349529A (en) * | 2015-12-09 | 2016-02-24 | 江苏正大天创生物工程有限公司 | Freeze-drying protective agent applied to nucleic acid amplification system |
CN105463125A (en) * | 2016-02-02 | 2016-04-06 | 江苏正大天创生物工程有限公司 | Nucleic acid amplification system and freeze-drying protective agent thereof |
CN105624311A (en) * | 2016-03-08 | 2016-06-01 | 湖南圣湘生物科技有限公司 | Real-time fluorescent PCR detection method and kit of multiple target nucleic acid in single tube |
CN106591432A (en) * | 2016-10-19 | 2017-04-26 | 珠海丽珠试剂股份有限公司 | Freeze-drying protective agent and freeze-drying method for RNA amplification reaction agent |
CN107287348A (en) * | 2017-06-19 | 2017-10-24 | 广州和实生物技术有限公司 | A kind of blood sieves three polychrome single tube detection kits |
Non-Patent Citations (2)
Title |
---|
张建中等: "POCT 核酸检测试剂的冷冻干燥处理及其应用", 《临床检验杂志》 * |
李伟等: "《分子诊断学》", 30 September 2015, 北京:中国医药科技出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114752662A (en) * | 2022-02-25 | 2022-07-15 | 福州迈新生物技术开发有限公司 | Fluorescent PCR (polymerase chain reaction) freeze-drying protective agent and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6534645B2 (en) | Compositions and methods enabling a totally internally controlled amplification reaction | |
Brechtbuehl et al. | A rapid real-time quantitative polymerase chain reaction for hepatitis B virus | |
Jung et al. | Quantitative pcr | |
RU2601129C2 (en) | Compositions and methods for quantifying a nucleic acid sequence in a sample | |
JP2009545317A (en) | Analyte and nucleic acid detection | |
JP2013240357A (en) | Ambient temperature stable kit for molecular diagnostic | |
CN111139313B (en) | Kit and method for efficiently and rapidly detecting and quantifying nucleic acid in serum or plasma | |
CN107988428A (en) | Shrimp irido virus(SIV)RAA constant temperature fluorescence detection method and reagent | |
US10689718B2 (en) | HEV Assay | |
CN108977580A (en) | A kind of kit of the quick detection hepatitis C virus nucleic acid of 2-8 DEG C of preservation | |
JP2014515920A (en) | Oligonucleotides comprising a label attached via a linker | |
US20240026438A1 (en) | Detection of nucleic acids using direct rt-pcr from biological samples | |
US20110306037A1 (en) | Oligonucleotuide probes and primers for detection of hepatitis b virus | |
CN111961762A (en) | Fluorescent RT-PCR primer, probe, reagent and method for detecting coronavirus SARS-CoV-2 | |
CN109735655A (en) | It is a kind of to detect DNA simultaneously and the multiple fluorescence PCR of RNA prestores freeze-dried reagent | |
GB2401175A (en) | Detection of SARS virus by PCR | |
US9394557B2 (en) | Linear amplification of short nucleic acids | |
KR102208001B1 (en) | Composition for simultaneous detection of porcine circovirus type 2 and type 3 and use thereof | |
WO2013101290A1 (en) | Methods of using telomeres as markers for aging | |
EP4265741A1 (en) | Multiplexable crispr-cas9-based virus detection method | |
EP2625284B1 (en) | Method for cell lysis in a rt-pcr reaction buffer | |
Callison et al. | Rapid differentiation of avian infectious bronchitis virus isolates by sample to residual ratio quantitation using real-time reverse transcriptase-polymerase chain reaction | |
US20230101834A1 (en) | Padlock probe-based rolling circle amplification paired with nuclease protection for point-of-need nucleic acid detection | |
US20130203120A1 (en) | Method for cell lysis and pcr within the same reaction chamber | |
EP4118205A1 (en) | Looped primer and loop-de-loop method for detecting target nucleic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190510 |
|
RJ01 | Rejection of invention patent application after publication |